Medtronic's SynchroMed pump hit by second Class I recall; fights it out with NuVasive over spinal patents
This article was originally published in Clinica
Executive Summary
The US FDA has designated Medtronic's alert about a potential defect with the batteries in its SynchroMed II implantable drug infusion pump as a Class I recall. This is the latest in a growing list of warnings and recalls linked to the device over the last few years, and involves the same problem that Medtronic encountered in July 2009.